Endogenous mammalian histone H3.3 exhibits chromatin-related functions during development by Kelly M Bush et al.
Bush et al. Epigenetics & Chromatin 2013, 6:7
http://www.epigeneticsandchromatin.com/content/6/1/7RESEARCH Open AccessEndogenous mammalian histone H3.3 exhibits
chromatin-related functions during development
Kelly M Bush1,2,3, Benjamin TK Yuen1,2,3, Bonnie L Barrilleaux1,2,3, John W Riggs1,2,3, Henriette O’Geen2,
Rebecca F Cotterman1,2,3 and Paul S Knoepfler1,2,3*Abstract
Background: The histone variant H3.3 plays key roles in regulating chromatin states and transcription. However,
the role of endogenous H3.3 in mammalian cells and during development has been less thoroughly investigated.
To address this gap, we report the production and phenotypic analysis of mice and cells with targeted disruption
of the H3.3-encoding gene, H3f3b.
Results: H3f3b knockout (KO) mice exhibit a semilethal phenotype traceable at least in part to defective cell
division and chromosome segregation. H3f3b KO cells have widespread ectopic CENP-A protein localization
suggesting one possible mechanism for defective chromosome segregation. KO cells have abnormal karyotypes
and cell cycle profiles as well. The transcriptome and euchromatin-related epigenome were moderately affected by
loss of H3f3b in mouse embryonic fibroblasts (MEFs) with ontology most notably pointing to changes in chromatin
regulatory and histone coding genes. Reduced numbers of H3f3b KO mice survive to maturity and almost all
survivors from both sexes are infertile.
Conclusions: Taken together, our studies suggest that endogenous mammalian histone H3.3 has important roles in
regulating chromatin and chromosome functions that in turn are important for cell division, genome integrity, and
development.
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Histone H3Background
The nucleosome is a dynamic structure whose constituent
histones undergo a vast number of posttranslational modi-
fications (PTMs), which influence nucleosomal function.
In addition, the histones can be entirely replaced by de-
position of variant histones carrying their own unique
complements of PTMs. For example, canonical histone
H3 proteins, H3.1 and H3.2, can be replaced by the his-
tone variant, H3.3. Deposition of H3.3 is thought to pro-
duce a nucleosomal state that is less structured and
associated with a more transcriptionally active state [1,2].
However H3.3 is not strictly associated with actively tran-
scribed genes and can be found at repressed and poised* Correspondence: knoepfler@ucdavis.edu
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reproduction in any medium, provided the orgenes as well [3,4]. One notion consistent with the rather
complex relationship between H3.3 and transcriptional
states is that H3.3 may be more of a boundary factor for
chromatin regulatory domains rather than directly pro-
moting the formation or maintenance of specific tran-
scriptional outcomes [5,6]. Intriguingly, H3.3 has recently
been implicated in cellular reprogramming [7] and is theo-
rized to play a key role in global changes in the transcrip-
tome linked to cellular fate.
Another H3 variant, CENP-A is essential for centromere
function where a role for histone H3.3 is also implicated
[8]. H3.3 may regulate centromeres at least in part by
directing appropriate CENP-A protein deposition [9].
While deposition of canonical H3 is replication dependent
(RD) and occurs in S phase, H3.3 is expressed [10] and can
be deposited either during S phase or in a replication-
independent (RI) manner throughout the cell cycle [11].
Nucleosome displacement by the RNA polymerase com-
plex within actively transcribed genes necessitates a higherd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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different phases of the cell cycle [2,12]. H3.3 is also depos-
ited at chromatin gaps, where it may have a unique func-
tion [13]. In addition to its role as a replacement for H3.1
and H3.2, H3.3 also has an antagonistic relationship with
histone H1 as a roughly 50% knockdown of H3.3 using
RNAi in fly cells substantially increased H1 genomic bind-
ing resulting in increased nucleosomal length [14].
The unique functions of the histone H3.3 protein are
conferred by the few amino acids by which it varies from
canonical histone H3 proteins, and by the distinct ex-
pression of H3.3 throughout the cell cycle. H3.3 protein
differs by only four and five unique residues from his-
tones H3.2 and H3.1, respectively. Residues S31, A87,
I89, and G90 are completely unique to H3.3. Histone
H3.3 phosphorylated at Serine31 (H3.3S31P) is enriched
at domains bordering centromeres during metaphase
and may function in mitosis [15], while amino acids 87,
89, and 90 of canonical H3 play a role in preventing
H3.1 and H3.2 from participating in RI deposition [11].
Rescue experiments determined that histone H3.3 and
H3 were unable to fully compensate for each other’s loss
[16]. A contributing factor to the incomplete rescues
may be distinct chaperones used to deposit H3 and
H3.3. Two separate chaperone complexes are known to
be responsible for H3.3 deposition, and in mouse mesen-
chymal stem cells (MSCs), are thought to recruit H3.3-H4
dimers at loading centers located in promyelocytic
leukemia (PML) bodies [17]. Histone regulator A (HIRA)
is a major and critically important H3.3 chaperone, in-
corporating H3.3 in a replication-independent manner
[18,19] into chromatin where active transcription is taking
place [3,20]. Meanwhile, the death associated protein,
DAXX, and the α-thalassemia X-linked mental retardation
protein, ATRX, deposit H3.3 into telomeric and pericen-
tric heterochromatin regions [21,22].
Only two genes, H3f3a and H3f3b (H3.3A and H3.3B in
Drosophila), encode the H3.3 protein, while more than a
dozen histone H3.1 and H3.2 genes encode the canonical
histone H3.1 and H3.2 proteins. The H3f3a and H3f3b
genes also are uniquely located outside canonical histone
gene clusters, and their gene structure is distinct from that
of canonical histone genes in that they have introns and
they also produce mRNAs with polyadenylated tails.
When compared to each other, H3f3a and H3f3b also have
distinct gene expression patterns, untranslated regions
and promoters [23].
Loss-of-function studies of the two H3.3 genes in
Drosophila, H3.3A and H3.3B, have provided key insight
into its role in cell biology [16]. While each gene is inde-
pendently dispensable for fly development, this is likely
due to redundancy as double H3.3 mutants have strong
phenotypes including infertility and reduced viability
[16,24]. Null flies also exhibit male meiotic defectsincluding impaired chromosome segregation [16]. The
biological function of histone H3.3 in higher-order species
remains relatively less clear, as most studies have only
been able to disrupt one of the two H3.3-encoding genes
[25,26] or knockdown expression of H3.3 and its chaper-
ones [27,28]. Knockdown of chromatin-bound H3.3 pro-
tein by means of H3.3-directed morpholinos [27], or by
the introduction of a dominant-negative form of H3.3 [28]
leads to mesodermal developmental defects, possibly due
to the inability to obtain sufficient levels of H3.3 to sustain
expression of genes involved in differentiation. In mam-
mals, one genetic loss-of-function study has been reported
involving a fertility screen-based gene trap of the histone
H3f3a gene [26]. The gene trap was not a null allele as it
reduced H3f3a expression only several fold. Nonetheless,
mice with the homozygous H3f3a gene trap mutation
exhibited some evidence of embryonic lethality and infertil-
ity even though H3f3b is also apparently highly expressed
along with H3f3a in testes [29]. Another study utilized
gene targeting vectors to substitute H3.3 encoding genes
with an H3f3a or H3f3b conditional allele [25], but did not
present phenotypic data.
Epitope tagging-based functional genomics studies in
MSCs and in mouse embryonic stem (ES) cells have
proven of great value in elucidating H3.3 chromatin func-
tion [3,4]. These studies indicated that H3.3 is enriched at
actively transcribed genes, but not exclusively, and H3.3
enrichment at cell type specific genes changed with differ-
entiation [3,4]. H3.3 was also found enriched in telomeric
and particularly pericentromeric heterochromatic regions
[21,22,30]. More recently, specific coding mutations in
H3f3a have been discovered by next generation sequen-
cing in human glioblastoma tumors [31-36]. The muta-
tions consistently changed K27 and G34, but with as yet
unknown functional consequences. Intriguingly, the H3.3-
related glioblastoma cancers also frequently possess muta-
tions in DAXX or ATRX.
Here, to further investigate the function of H3.3, we
report a knockout of H3f3b in mice. H3f3b KO mice had
a semilethal phenotype and survivors were nearly all in-
fertile. The mechanisms underlying these phenotypes
converge on cell division, as evidenced by using mouse
embryonic fibroblasts (MEFs) as a model. Loss of H3.3
was associated with ectopic CENP-A localization as well
as spreading of pericentric heterochromatin. Moderate
changes in the transcriptome and epigenome of KO cells
were also measured. Overall, our studies provide novel
insights into the chromatin and biological functions of
histone H3.3.
Results
Production and validation of H3f3b knockout mice
To address H3.3 function in development and chromo-
some biology, we used homologous recombination to
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the entire coding region contained within exons 2 to 4 is
flanked by loxP sites (floxed; Figure 1A). The H3f3b locus is
6 to 9 kb from the nearest neighbor genes (Additional file 1:
Figure S1A). Genomic PCR genotyping assays for the
wildtype (WT), floxed (Fl), and null (H3f3bΔ) alleles of
H3f3b were developed (primer locations are indicated in
Figure 1A by horizontal arrows) and used to validate the
genotypes of the mice (Additional file 1: Figure S1B).
H3f3bFl/WT mouse embryonic stem cells were injected into
blastocysts to produce chimeras, which were then bred
with wildtype mice. Chimeras exhibited germ-line trans-
mission of the H3f3bFl allele producing H3f3bFl/WT pups,
and several from one chimera were used as founders. The
germline deleter Cre transgene, Zp3-Cre, which is highly
expressed early in oocyte development [37], was used to
produce H3f3bΔ alleles from floxed alleles. Southern blot-
ting of genomic DNA from H3f3bFl/Fl, H3f3bWT/WT (WT),
and H3f3bΔ/Δ(KO) animals using two separate probes
(5’ and 3’) (Additional file 1: Figure S1C) produced the
expected bands for each allele (Figure 1B,C). When we
conducted chromatin immunoprecipitation-sequencing
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Figure 1 Generation and validation of conditional, floxed and constit
wildtype (WT) H3f3b allele. (second row) The targeting vector contains loxP
5.3 kb 3’ arm of homology, diphtheria toxin A (DTA) cassette, and a neomy
element allows for positive selection in embryonic stem (ES) cells, while th
homologous recombination of the conditional knockout construct, the H3f
(bottom), deleting the entire coding sequence (CDS). (B) Southern blotting
kb and 17 kb bands, respectively validating appropriate gene targeting. (C)
kb bands for KO and WT alleles in the samples of the indicated genotypes.
Mapped reads from ChIP-Seq assays on KO and WT mouse embryonic fibro
and histone 3 lysine 9 acetylation (H3K9ac) indicate precise deletion of the
marks. (E, F) qPCR of H3f3b (E) and H3f3a (F) mRNA levels in MEFs of indica
MEFs. Error bars are standard deviations. ND = none detected.H3f3b KO MEFs we found further, independent evi-
dence of precise deletion of the H3f3b floxed region
(Figure 1D). For both histone H3 lysine 9 acetylation
(H3K9ac) and histone H3 lysine 4 tri-methylation
(H3K4me3) marks, mapped reads were evident at the
H3f3b locus corresponding with the transcribed exons in
WT cells. Importantly, the floxed region (bracketed) in
H3f3b KO mice had no reads mapping to the locus, but
the H3K9ac and H3K4me3 reads mapping to Exon 1,
which should not be deleted in the floxed allele by Cre,
remained. As a control, H3f3a had the same read profiles
in both H3f3b WT and KO cells (Figure 1D, bottom).
These data argue for a very precise function of our floxed
H3f3b allele in the presence of Cre.
Validation of the conditional and constitutive H3f3b KO
alleles at the mRNA level
Primary MEF cell lines were isolated from E12.5 embryos
produced from heterozygous (Het, H3f3bΔ/WT) intercrosses
and stable MEF primary lines of each genotype (WT, Het,
and KO) were established. Although we established many
lines of H3f3b WT and H3f3b KO MEFs, in this paper we
will focus primarily on those from three specific litters: (1)2.3
GFP Cre



































utive knockout (KO) alleles of the H3f3b gene. (A) (top) The
sites (triangles) that flank exons 2 to 4, a 4.3 kb 5’ arm of homology, a
cin (Neo) cassette flanked by frt sites (vertical double arrows). The Neo
e DTA element permits negative selection in ES cells. (third row) After
3b gene is expressed until Cre-mediated deletion of exons 2 to 4
of H3f3b WT and floxed mice using a 3’ probe yields the expected 20
Southern blotting using a 5’ probe generates the predicted 20 and 10
With this probe a background band (*) was present in all samples. (D)
blasts (MEFs) 1 and 2 for histone 3 lysine 4 tri-methylation (H3K4me3)
H3f3b floxed region with undeleted Exon 1 still exhibiting histone
ted genotypes. (G) qPCR assay of H3f3b mRNA levels in conditional KO
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WT46, WT48; and (3) KO56 versus WT63. The rationale
for choosing and studying MEFs for these initial analyses
was that they are a useful cell type that can be reproducibly
isolated from midgestational embryos (prior to lethality)
for interrogating the KO phenotype. We conducted qPCR
on RNA isolated from low passage (<8) MEFs of each line,
validating that the H3f3bΔ allele was a null as KO MEFs
had no detectable H3f3b (ND = none detected), and find-
ing, as expected, that Het MEFs exhibited an appro-
ximately two-fold reduction in H3f3b mRNA levels
(Figure 1E). We used qPCR to examine the possibility that
there might be compensatory increases in H3f3a mRNA
levels in H3f3b KO MEFs (Figure 1F). Both KO1 and KO2
showed an increase in H3f3a mRNA, but KO2 exhibited a
more severe reduction in H3.3 protein levels (Additional
file 2: Figure S2B, D). We also examined levels of H3f3a in
uncultured E13.5 embryonic tissue (Additional file 2:
Figure S2A). Although we saw a slight relative elevation in
H3f3a expression in KO 112 and KO 116, it is difficult to
say whether or not H3f3a has a compensatory effect dur-
ing development. Overall, data on a number of MEF lines
(Figure 1F and Additional file 2: Figure S2B) indicate sig-
nificant heterogeneity among H3f3b KO MEF lines in po-
tential compensatory upregulation of H3f3a levels as well
as in H3.3 and H3.3S31P protein levels (Additional file 2:
Figure S2B-D). For example, one H3f3b KO line, KO52,
exhibited an approximately three-fold upregulation of
H3f3a expression. This increase is also apparent at the
protein level, with KO52 expressing roughly three fold
more H3.3 than littermate KO49 (Additional file 2: Figure
S2C, D).
To validate the targeted allele, we produced H3f3bFl/Fl
MEFs and transduced them with retrovirus encoding ei-
ther GFP (control) or a GFP-Cre bicistron. Relative to
control, H3f3bFl/Fl MEFs transduced with Cre exhibited
a 44-fold reduction in H3f3b levels (Figure 1G). Thus,
the floxed allele is functional and deleted by Cre.
The H3f3b knockout is semilethal and impairs embryo
growth
Heterozygous animals were present in slightly less than
expected Mendelian ratios at maturity suggesting a low
level of lethality, but they exhibited no outwardly appar-
ent phenotype and were fertile. When Het mice were
intercrossed, surviving mature KO animals arising from
those litters were significantly underrepresented (0.01 <
P <0.05), indicating semilethality (Figure 2A). Such surviv-
ing mature KO animals exhibited no outwardly apparent
phenotype other than almost uniform infertility in females
and complete infertility in all males.
To measure possible embryonic lethality of KO animals,
timed matings were conducted using Het parents. Normal
Mendelian ratios were observed at E12.5 for KO (Figure 2A),suggesting that the H3f3b knockout phenotype predomin-
antly produces lethality in the second half of embryogenesis.
However, most KO E12.5 embryos exhibited visibly appar-
ent, abnormal development (Figure 2B,C) indicative of a
broad failure of embryo growth. Immunostaining of MEFs
using an H3.3-specific antibody [22] revealed both diffuse
and punctate H3.3 protein nuclear staining, mostly but not
completely outside of heterochromatic foci (Figure 2D).
The H3.3 staining was greatly reduced in the H3f3b KO
MEFs.
Loss of H3f3b leads to chromosomal bridge formation,
severe karyotypic abnormalities and endoreduplication
H3f3b KO MEFs exhibited relatively high levels of mi-
totic figures and KO mitotic cells had a 17-fold increase
in chromosomal bridges (Figure 2E; WT 0.049% versus
KO 0.84%, P = 0.002), evidence of failure to properly
transit mitosis with H3.3 loss-of-function. To examine
the potential effects of H3.3 loss-of-function on genomic
integrity, two WTand two H3f3b KO littermate MEF lines
were karyotyped (Figure 3A, Additional file 3: Figure S3A,
C, and Table 1). During the analysis, 35 spreads each for
WT1 and WT2 and 34 and 33 spreads for KO1 and KO2,
were read respectively. The karyotypes of the two WT
lines had a mean of 65.7% normal spreads, with only low
levels of abnormal chromosome numbers that are some-
times observed in WT MEFs [38] (Additional file 3: Figure
S3A). The few WT spreads that had abnormalities pre-
dominantly exhibited a low rate of breaks (usually just one
or two per spread) (Table 1). The two H3f3b KO lines had
substantially lower genomic integrity with a mean of
47.8% normal spreads. In addition, the abnormal KO
spreads exhibited far higher levels and more severe types
of chromosomal aberrations than did the WTs. These
changes in the KOs included rearrangements, fragmented
ends, multiple tri-radial chromosomes, and intriguingly, in
both KO lines, endoreduplication (Figure 3A, Additional
file 3: Figure S3A, C, and Table 1). KOs had more than a
four-fold increase in spreads with more than two chromo-
somal abnormalities (Table 1).
H3f3b removal results in increased pericentric
heterochromatin
We utilized DAPI staining to further analyze nuclear struc-
ture during interphase in two separate H3f3b KO and WT
MEFs (H3f3b KO lines 49 and 52; H3f3b WT lines 46 and
48) (Figure 2F,G). Overall, after examining multiple Z-stack
sections through individual nuclei (Figure 2F, top), we
found that H3f3b KO MEFs prepared identically to H3f3b
WT MEFs exhibited a 1.5-fold increase (P = 4.49E-05,
n = 81 H3f3b KO and n = 93 H3f3b WT nuclei) in DAPI
mean fluorescence intensity (MFI). We separately verified
the observed increase in DAPI MFI by taking single ex-











































































































E12.5 P21 or later
KO
Figure 2 Loss of H3f3b causes a semilethal phenotype and in a subset of embryos strongly impairs overall growth. (A) Ratios of animals
of the indicated ages from heterozygous intercrosses indicate substantial lethality among mature knockout (KO) animals.* 0.01 < P <0.05 by Chi
Square. (B, C) KO E12.5 embryos exhibit strong reductions in overall growth. Scale bar = 1 mm. (D) Wildtype (WT) 63 and KO 56 E12.5 mouse
embryonic fibroblasts (MEFs) stained with anti-H3.3 antibodies show higher levels of H3.3 in WT MEFs. (E) Chromosomal bridges were observed
much more frequently in KO nuclei than in WT nuclei. DAPI staining of a KO 56 nuclei shows representative example of a KO chromosomal
bridge. (F) H3f3b KO MEFs exhibit a statistically significant 1.45 to 1.5-fold increase in DAPI mean fluorescence intensity (MFI) per nuclei, and a
1.21 to 1.36-fold increase in the amount of DAPI MFI per unit of nuclear area. (G) H3f3b KO MEFs display a significant 1.30 to 1.5-fold increase in
the number of pericentric heterochromatic DAPI foci per nuclei, and a significant increase in the number of DAPI-positive foci per unit of nuclear
area. Scale bars = 10 um.
Bush et al. Epigenetics & Chromatin 2013, 6:7 Page 5 of 16
http://www.epigeneticsandchromatin.com/content/6/1/7n = 309 H3f3b KO, P = 2.85E-176; data not shown). This
increase in DAPI intensity was also significantly higher in
H3f3b KO MEF nuclei when normalized to nuclear area
(P = 6.02E-05, Figure 2F, bottom). In addition, we exam-
ined the number of intense DAPI foci in H3f3b WT and
KO MEF nuclei to determine whether the increase in
DAPI intensity corresponded to a spread in pericentric
heterochromatin [39]. Loss of H3f3b resulted in a 1.3-fold
increase in the number of pericentric heterochromatin
foci (P = 6.03E-3, n = 81 H3f3b KO and n = 93 H3f3b WT)
per MEF nuclei (Figure 2G, top). There was also a signifi-
cant 20% increase in the number of pericentric heterochro-
matic foci when this data was normalized to nuclear area
(P = 0.04, Figure 2G, bottom). In agreement with this data,
a separate set of H3f3b KO nuclei analyzed under identical
conditions were found to have a 1.5-fold increase in thenumber of foci per nuclei (P = 6.94E-4, n = 84 H3f3b KO
and n = 101 H3f3b WT nuclei, not shown).
H3.3 is required for appropriate CENP-A localization
We hypothesized that the changes in nuclear architec-
ture and compromised genomic integrity in H3f3b KO
MEFs might be due to centromeric dysfunction. To dir-
ectly examine this possibility, we co-stained interphase
cells from two H3f3b KO and WT lines with CREST, a hu-
man antiserum against the centromere that recognizes a
variety of centromeric proteins, and with a specific CENP-
A antibody (Figure 3B). H3f3b KO MEFs displayed signifi-
cant increases in kinetochore protein levels by immuno-
cytochemistry. More specifically, KO nuclei generally had
increased numbers of both CREST and CENP-A foci cor-





































































p = 1.17E-07 p = 2.31E-02
Figure 3 H3f3b knockout (KO) mouse embryonic fibroblasts (MEFs) exhibit chromosomal bridges, severe karyotypic abnormalities,
and ectopic staining of CENP-A and CREST. (A) Karyotyping revealed a number of types of abnormalities in H3f3b KO MEFs not observed in
wildtype (WT) MEFs including endoreduplication, chromosomal fragmentation, and tri-radial chromosomes (See also Additional file 3: Figure S3
and Table 1). (B) Staining of WT 63 and KO 56 cells with CREST and CENP-A antisera (green and red in merge, respectively). (C) KO MEFs with
chromosomal bridges had higher levels of CREST and CENPA foci (white arrows). (D) Quantification of foci staining for KO 49 and 52 versus WT
46 and 48. An average of 17 confocal sections per nuclei were analyzed using ImageJ software as in this study [43]. Scale bars = 10 um.
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(Figure 3B). The majority (but not all) of CREST and
CENP-A foci co-localized with DAPI-positive pericentric
heterochromatic foci in H3f3b KO and WT MEFs. Those
KO nuclei exhibiting abnormal mitotic figures and chromo-
somal bridges had particularly high levels of CREST stain-
ing (Figure 3C) including in the bridges themselves.
Quantitation of CENP-A and CREST foci as well as MFI by
semi-automated ImageJ-based analysis (n = 94 H3f3b WT
and n = 81 H3f3b KO MEF nuclei) indicated that H3f3b
KO MEFs had significant increases in both CENP-A and
CREST foci and total nuclear signal for CENP-A and
CREST (Figure 3D). More specifically, H3f3b KO MEFs
exhibited a 1.95-fold increase in CREST (P = 2.25E-12) and
a 1.45-fold increase in CENP-A (P = 1.03E-03) per nucleus
by immunofluorescence. Additionally, H3f3b KO MEFsdisplayed a 1.55-fold increase in the number of CREST-
positive foci (P = 1.17E-07) and a 1.2-fold increase in the
number of CENP-A-positive foci (P = 2.31E-02) per nuclei
when compared to WT (Figure 3D). H3f3b KO MEF nu-
clei also exhibited higher levels of CREST (P = 1.71E-16)
and CENP-A (P = 8.95E-03) per unit of nuclear area when
compared to H3f3b WTMEFs (data not shown). To verify
these findings, we analyzed a separate set of H3f3b WT
and KO MEF nuclei under identical conditions (n = 91
H3f3b WT and n = 86 H3f3b KO), and again found sta-
tistically significant increases in the number of CREST-
(P = 0.017) and CENP-A-positive foci (P = 0.004) per
nuclei in H3f3b KO MEFs (data not shown). Despite
these changes, kinetochore staining by CREST still lo-
calized to the centromeres of the mouse acrocentric
chromosomes during metaphase (Additional file 3: Figure
















WT1 35 26 5 0 2 0 0 0 0
WT2 35 20 10 2 0 4 0 0 0
Total
WT
70 46 15 2 2 4 0 0 0
%
Total
65.7% 21.4% 2.9% 2.9% 5.7% 0% 0% 0%
KO1 34 16 6 5 4 4 1 1 1
KO2 33 16 6 3 6 6 2 1 2
Total
KO
67 32 12 12 10 10 3 2 3
%
Total
47.8% 17.9% 17.9% 14.9% 14.9% 4% 3% 4%
Karyotype analysis done on E12.5 WT (H3f3bWT/WT) and KO (H3f3bΔ/Δ) MEFs (lines WT1, WT2 and KO1, KO2 respectively). Normal spreads included typical
metaphase spread preparation artifacts. Typical artifacts were the loss of 1 to 2 chromosomes per spread. KO MEFs exhibited a greater incidence of abnormalities.
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global histone H3 distribution by Immunocytochemistry-
Immunofluorescence (ICC-IF) (Additional file 3: Figure
S3E). Because H3.3 was found to incorporate into mouse
telomeric chromatin [21,30], we utilized fluorescent in-
situ hybridization (FISH) to determine whether nuclear
integrity could also be affected by dysregulation at the
telomere level using a telomere-specific peptide nucleic
acid probe. We did not detect a consistent difference in
telomere probe hybridization between the H3f3b KO and
WT MEF nuclei (Additional file 4: Figure S4).
Loss of H3f3b has moderate, but potentially functionally
important overall effects on the transcriptome in mouse
embryonic fibroblasts
An H3.3-specific antibody [22] was used to immunoblot
acid extracts from two independent H3f3b⋅KO MEF lines,
KO1 and KO2, which both exhibited greater than 70% re-
ductions in total H3.3 protein relative to WT littermates
(Figure 4B and Additional file 2: Figure S2C, D). Two add-
itional KO MEF lines, KO49 and KO52 exhibited similar
reductions in H3.3 protein levels as well (Additional file 2:
Figure S2C, D). Therefore, we theorized that potential ef-
fects of strongly reduced H3.3 levels on the transcriptome
should be measurable by array. In light of a recent paper
[40] associating microarray results with total RNA levels
or production, we analyzed three KO and three WT lines
to determine total RNA levels. Although the trend was for
KOs to have modestly lower total levels of RNA, there was
no statistically significant difference with loss of H3f3b
(Additional file 5: Figure S5A). Importantly, total H3.3
protein levels did vary between H3f3b knockouts, sug-
gesting variable compensatory effects or expression of
H3.3 protein by H3f3a. One KO line, KO2, had H3.3 levels
that were only 5% of WT, while KO1 had 28% of WT
levels (Figure 4B and Additional file 2: Figure S2C, D).To analyze the potential effects of the knockout of
H3f3b on gene transcription, we isolated RNA from
H3f3b WT and H3f3b KO MEFs derived from litter-
mate E12.5 embryos and conducted expression micro-
array studies (Figure 4A). We also conducted parallel
conditional KO array experiments on H3f3b Fl/Fl MEFs
transduced with either GFP (control) or GFP-Cre (KO).
Disruption of H3f3b and concomitant loss of most
H3.3 protein in MEFs caused a moderate detectable
change in the global transcriptome (Additional file 6:
Table S1; Additional file 7: Table S2 and Figure 4A).
Employing a two-fold or greater expression change cutoff
in MEFs, only 28 and 3 genes were upregulated by con-
stitutive and conditional loss of H3f3b, respectively. Only
88 and 111 genes were consistently downregulated in
both of two biological replicates each of constitutive and
conditional H3f3b KO MEFs, respectively. The most
highly downregulated gene in KO MEFs was the H3f3b
gene itself in every case. Expanding our analysis to genes
with expression changes of 1.5 fold or more produced
subgroups of 153 and 103 genes upregulated and 318
and 353 genes downregulated with constitutive and con-
ditional deletion of H3f3b, respectively.
The ontology of genes with altered transcription in H3f3b
knockout mouse embryonic fibroblasts suggests a core
relationship of H3.3 with the chromatin and cell cycle
regulatory machinery
Although loss of H3f3b did not cause pronounced global
activation or repression of the overall transcriptome, some
of the gene expression changes may be meaningful for the
observed phenotypic outcomes. Ontological analysis of
genes with altered expression due to loss of H3f3b pointed
to the following significant functional clusters: histone,
centromere-related, mitotic regulatory factor, and DNA











































































































































































































































































































p = < 1.0E-2
Figure 4 The ontology of transcriptome changes with loss of H3f3b indicates changes in histone, centromere, mitotic, and DNA
synthesis genes. (A) RNA isolated from control and H3f3b knockout (KO) mouse embryonic fibroblasts (MEFS) (wildtype (WT)1,2 versus KO 1,2)
was used for expression microarray studies. Gene expression changes are reported as green and red bars for down and upregulated genes
respectively based on the indicated cutoffs for fold changes. (B) Immunoblot for H3.3 protein demonstrating strong reductions in total H3.3 and
changes in other histone mark protein levels in the two KO MEF lines used for array and ChIP-Seq studies. (C) Average gene expression levels of
downregulated histones consistent between conditional and constitutive array. (D) An ontological cluster of downregulated centromeric genes
was evident consistently in H3f3b KO MEFs. (E) Data from arrays on WT and KO MEFs indicated a very large ontological cluster of mitotic
regulatory genes is downregulated in the absence of H3f3b. (F) DNA synthesis genes downregulated as measured by microarray. (G) KO1 MEFs
had significantly larger and rounder nuclei compared to littermate MEF WT1. (H) Cell cycle analysis by flow cytometry for DNA content on WT
MEFs 46 and 48 versus KO MEFs 49 and 52 revealed, when quantitated, as shown in (I) a 40% increase in G2/M phase in KO cells. Error bars in
(B-E, G, I) are standard deviations. *2610039 is an abbreviation for the 2610039C10Rik gene whose protein product has a mitotic ontology.
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and constitutive KO data; Figure 4D, mean of condi-
tional KO). The ontological cluster of cell cycle regulatory
factors had particularly high statistical significance (P =
3.1E-10), and included most prominently, eighteen import-
ant mitotic regulatory genes (P = 2.6E-6; Figure 4E). qPCR
validated the decreases in four of six centromeric/mitotic
genes tested: CENP-A, Birc5, Cdc20, and Dbf4 and also the
DNA synthesis gene Rrm1 (Additional file 5: Figure S5B).
Despite significant ontological clusters, it is notable that
the fold changes in genes in the clusters mentioned above
were themselves very moderate by array, possiblyexplaining why only some expression changes were able to
be validated by qPCR.
Changes in overall histone levels with loss of H3f3b in
mouse embryonic fibroblasts
Since ontology analysis of our expression array data indi-
cated widespread changes in histone family genes, we ex-
amined histone family protein levels by immunoblotting
(Figure 4B). Six members of the Hist1H2a gene family, all
encoding histone H2a protein, were downregulated (data
are means of both the constitutive and conditional H3f3b
KO MEFs relative to mean of WT samples; Figure 4C) at
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them at most mildly decreased in H3f3b KO MEFs. Two
histone H3 family members (CENPA and Hist1H3b) were
also downregulated at the mRNA level. We observed moder-
ate decreases in CENP-A via immunoblot (Additional file 5:
Figure S5E) but we did not see consistent changes in H3
protein levels in different KO lines (Figure 4B, Immuno-
staining; Additional file 3: Figure S3E). Focusing on his-
tone genes moderately upregulated in the array study
from constitutive KO data (Additional file 5: Figure S5C),
we saw no consistently clear changes in their protein levels
(Additional file 5: Figure S5D). Regarding H3.3 protein
levels, since the constitutive H3f3b KO MEFs lines had
very low total H3.3 protein levels, H3f3b may have a more
dominant role in H3.3 protein production in MEFs than
H3f3a (Figure 4B and Additional file 2: Figure S2C, D).
Histone H3 marks including histone 3 phosphorylation at
serine 10 (H3S10P), H3K4me3 and H3K9ac were also ob-
served as reduced in the H3f3b KO cells, but perhaps not
to the same degree as H3.3. Interestingly, at the protein
level, all analyzed KO lines exhibited relative hyper-
phosphorylation of H3.3 at Serine 31 perhaps in compen-
sation to more pronounced reductions in total H3.3
protein (Additional file 2: Figure S2C, E).
H3f3b knockout cells exhibit abnormal nuclear
architecture with larger, more rounded nuclei
We analyzed images of DAPI-stained nuclei from WT1
and KO1 cell lines using the R package EBImage
(http://www.bioconductor.org/). MEFs lacking H3f3b have
abnormal nuclei in terms of both volume and shape
(Figure 4G and Additional file 3: Figure S3B). H3f3b KO
MEFs exhibit a greater than 40% mean increase in nuclear
volume (Figure 4G), but a more compact morphology as
measured by shape factor suggesting that loss of H3f3b
may affect nuclear architecture/chromatin structure over-
all. We repeated this analysis using WT46 and WT48
compared to KO49 and KO52 and observed the same
trends in nuclear volume and shape (data not shown).
These global alterations in nuclear structure are also asso-
ciated with brighter DAPI staining evident in the KO nu-
clei. The large nuclear size of some KO MEFs also was
consistent with a subpopulation endocycling (Figures 3A,
4G, and Additional file 3: Figure S3B, C) [41].
Loss of H3f3b alters cell cycling with increased G2/M phase
To examine cell cycle profiles more directly, cell lines
WT46, WT48 and KO49, KO52 were analyzed by flow cy-
tometry for DNA content (Figure 4H,I). H3f3b KO cells
exhibited a nearly 40% increase in G2/M cells (P value
<0.01), increasing from 20% to 28%. The G0/G1 phase
fraction was decreased from 54% to 42% of the population.
While fifteen critical DNA synthesis regulatory genes, in-
cluding all the main genes of the minichromosomemaintenance complex (MCM), were downregulated as
assessed by array (Figure 4F), no significant change in the
percent of cells in S phase was evident in the KO (Figure 4-
I) and the apparent changes in expression of each MCM
gene by array were very small. Together, the decrease in
G0/G1 cells, along with no change in S phase levels and
the pronounced increase in G2/M cells support a model
in which KO cells are at times blocked in M. The high fre-
quency of chromosomal bridges in the KO cells compli-
cates comparative (WT versus KO) measurement of
mitotic cells by flow cytometry, as cells with mitotic bridges
are likely to be destroyed during the process. As a result,
we speculate that the H3f3b KO mitotic arrest is even
more pronounced than evident in the flow cytometry data
in Figure 4I.
Moderate loss of genomic H3K4me3 and H3K9ac peaks in
H3f3b knockouts as measured by chromatin
immunoprecipitation-sequencing
To examine potential regulation of euchromatic states
more generally by H3.3, we immunostained WT and
H3f3b KO MEFs for H3K4me3, a classic euchromatic
mark. We observed a modest, but consistent decrease in
H3K4me3 staining in KO MEFs (Figure 5A). To more
rigorously measure the potential functions of H3f3b and
H3.3 in regulating mammalian chromatin, we conducted
ChIP-Seq in WT and H3f3b KO MEFs for two euchro-
matic histone H3 marks, H3K9ac and H3K4me3
(Figure 5B). For each condition we sequenced biological
duplicates and genotype-matched input controls (Add-
itional file 10: Table S5). We aligned them to the mouse
genome mm9 with Bowtie. We used two different peak
callers, Sole Search (korflab.ucdavis.edu/software.html)
and PeakRanger (http://ranger.sourceforge.net), which
yielded very similar results. Sole Search peaks from bio-
logical duplicates had 95 to 98% overlap (Additional file
11: Figure S6A). When biological duplicates were merged,
ChIP-Seq peaks for each condition revealed a high degree
of overlap between WT and KO profiles of H3K9ac (91%
of WT peaks were present in KO) and H3K4me3 (93% of
WT peaks were present in KO) (Figure 5B). We used the
R package DiffBind (http://www.bioconductor.org) to per-
form affinity clustering analysis of PeakRanger peak sets,
in order to cluster the ChIP-seq samples based on tag
density (Figure 5C). We observed very high correlation be-
tween all samples for each histone mark (correlation >0.9).
For both H3K9ac and H3K4me3, KO and WT duplicate
samples in each case failed to cluster together, indicating
few reproducible differences in histone modification pat-
terns between KO and WT.
DiffBind was then used to perform edgeR differential
binding analysis. Surprisingly few H3K9ac peaks were
identified by DiffBind as significantly different (FDR <0.1)

















Figure 5 Global changes in genomic levels of H3K9ac and H3K4me3 with loss of H3f3b suggest a moderate role for H3.3 in
euchromatin. (A) Immunostaining in wildtype (WT) 63 versus knockout (KO) 56 indicates a modest decrease in global histone 3 lysine 4 tri-
methylation (H3K4me3) levels in KO nuclei. Scale bar = 10 um. (B) ChIP-seq analysis of H3K4me3 and histone 3 lysine 9 acetylation (H3K9ac) marks
was performed, normalizing samples to input for peak calling. Venn diagrams show the number of total and overlapping peaks in WT and KO
samples. Note, that for each condition the data presented are total peak numbers from merged biological duplicates of WT1 and WT2 versus KO1
and KO2. The number and percentage of overlapping peaks are indicated in the middle of each diagram. (C) Binding affinity clustering heatmap
of H3K9ac (left) and H3K4me3 (right) peaks in two biological replicates of WT and KO MEFs. Correlation color codes are shown above each plot.
Clustering was performed using R package DiffBind, which clusters the samples based on the normalized read counts for each sample at each
putative histone mark peak.
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for H3K4me3 with 105 peaks increased and 203 peaks
decreased for H3K4me3 (Additional file 12: Table S6).
We used the peak2gene tool at Galaxy Cistrome
(http://cistrome.org/ap/) to identify genes within 30 kb of
significantly changed peaks (Additional file 12: Table S6).
For both histone marks, the H3f3b locus itself was among
the most significantly reduced peaks, which is expecteddue to the absence of reads mapping to that locus in KO
samples. Gene ontology analysis of genes near differentially
modified H3K4me3 peaks reveals that peaks reduced in
KO are preferentially located near genes related to extracel-
lular matrix (enrichment score = 6.3), while peaks increased
in KO are preferentially located near genes related to pro-
tein kinases (enrichment score = 4.0) (Additional file
13: Table S7).
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(Figure 4B), twice as many H3K4me3 peaks were signifi-
cantly reduced as were increased by loss of H3f3b,
suggesting a possible reduction in euchromatin. However,
no statistically significant differences in peak heights or
widths were observed consistently between WT and KO
samples (Additional file 10: Table S5), nor was any consist-
ent loss of H3K4me3 or H3K9ac observed in the vicinity of
transcription start sites (TSS) in genic regions (Additional
file 11: Figure S6B). H3K4me3 peaks gained and lost in the
H3f3b KO cells were mapped relative to their distance
from centromeres (Additional file 14: Figure S7), discern-
ing no specific pattern spatially relative to centromeres.
We compared unique H3K9ac and H3K4me3 peaks
from WT and KO MEFs to an existing data set of CTCF
peaks in MEFs to determine whether changes in histone
marks could be specifically occurring near CTCF-
associated chromatin boundaries [42]. We examined two
sets of peaks from our data: the peaks that overlap be-
tween WT and KO (shared peaks), and peaks that do
not overlap between WT and KO (unique peaks). We
did not find a correlation between unique peaks and
CTCF binding sites. For H3K4me3, 42% of shared peaks
and 40% of unique peaks are within 1000 bp of a CTCF
peak (P = 0.042). For H3K9ac, 41% of shared peaks and
40% of unique peaks are within 1000 bp of a CTCF peak
(P = 0.16). Unique peaks are therefore not preferentially
found near insulator boundaries marked by CTCF bind-
ing, suggesting no major connection of H3.3 with insula-
tor function (data not shown).Discussion
Disruption of H3f3b, one of the two H3.3-encoding genes
in mice, lowers H3.3 protein levels sufficiently to induce
developmental, cellular, transcriptional and chromatin-
related phenotypes. Our studies suggest that one predom-
inant developmental function of histone variant H3.3 is
facilitating chromosome segregation at least in part trace-
able to delineation of appropriate pericentric hetero-
chromatin and CENP-A-bound chromatin domains. Our
results are in line with a previously published study in
which loss of the critical K27 residue of murine H3.3 ul-
timately results in chromosome segregation defects and
disruption in pericentric chromatin [43].
H3.3 interacts directly with DAXX, and in complex with
ATRX [21]. DAXX was shown to be the primary cha-
perone involved in the incorporation of epitope-tagged
H3.3 protein into MEF chromatin, and both DAXX and
ATRX are found to be strongly enriched at pericentric
DNA repeats [22]. Removal of ATRX, which targets DAXX
to the pericentric region, disrupts pericentric heterochro-
matin composition in oocytes, at least partially because of
a failure to recruit DAXX to these genomic regions. Thisultimately leads to increased incidences of aneuploidy and
chromosome segregation defects [44].
Pericentric DNA is transcribed during S-phase and dur-
ing mitosis in mouse cells [45], and the regulation of proper
amounts of pericentric transcript has been implicated by
numerous studies to be involved in both proper pericentric
heterochromatin formation (reviewed in [46]) and in appro-
priate chromosome segregation [43,47]. Pericentric DNA
transcription was found to be altered when critical H3.3
residues were changed [43], and upon knockdown of H3.3
by siRNA or loss of DAXX [22]. These published findings
combined with our data here, lead us to hypothesize that
deposition of H3.3 plays a role in the regulation of pericen-
tric heterochromatin.
Targeted disruption of H3f3b and the resulting de-
crease in H3.3 protein lead to a spectrum of severe
karyotypic abnormalities, an increase of cells in G2/M-
phase of the cell cycle, and an increased incidence of
chromosomal bridges. We theorize that these specific
phenotypic changes are linked. One model explaining
these observations invokes a connection between the
proper amounts of H3.3 protein in pericentric hetero-
chromatin and the generation of appropriate levels of
pericentric transcript. Disruption of either component
could lead to defects in chromosome segregation and
chromatid cohesion during cell division [47]. In this re-
gard, future studies will need to address pericentric tran-
script levels in the H3f3b KO MEF lines examined here.
Our data also demonstrate an increase in pericentric
heterochromatin, kinetochore, and CENP-A foci in
interphase nuclei. One published model for H3.3 func-
tion describes H3.3 acting in a gap-filling manner fol-
lowing transcription, possibly in part to protect DNA
[13,20]. Following H3.3 loss in Drosophila, H3.3 chaper-
ones ATRX/DAXX were found to maintain association
in place of H3.3 in regions normally bound by this his-
tone variant [13]. Thus, another possible explanation for
the observed karyotypic and chromosome segregation
defects may be the aberrant deposition of other factors
involved in kinetochore function, such as CENP-A, in
regions normally bound by H3.3 that may affect the
organization of proper centromere or heterochromatin do-
mains. Supporting this finding, H3.3 was found to be de-
posited in centromeric chromatin as a placeholder for
CENP-A [9]. In addition, H3.3 was shown to inhibit the
spread of heterochromatin domains in Drosophila [48].
The aberrant spread of factors, such as CENP-A, outside
of their normal chromatin domains as observed by staining
could also potentially result in the observed increased rates
of chromosome/chromatid fragments and breaks, cell cycle
defects, and chromosomal bridges, leading to tri-radial or
rearranged chromosomes. Although we were not able to
detect an increase in CENP-A protein expression by
Western blot on whole MEF cell extracts, this may be due
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staining (showing nuclear CENP-A) and blotting (whole
cell CENP-A) methods.
It is formally possible that the observed increases in
pericentric heterochromatin, kinetochore, and CENP-A
foci could be due to increased DNA content within the
H3f3b KO MEFs. Although we did not observe increased
rates of polyploidy in H3f3b KO MEFs when compared
to WT, it is possible that our karyotyping analysis may
have missed such events that ultimately resulted in cell
death, thereby removing these MEFs from the popula-
tion prior to analysis. However, our findings of signifi-
cant, but moderate increases in CENP-A and CREST
foci are not sufficiently supported mechanistically simply
by an increase in DNA content as (1) the rates of
endoreduplication in our karyotyping analysis were ex-
tremely low (3%); (2) the absolute percentage of cells
found to be in G2/M-phase of the cell cycle in H3f3b
KO MEFs was only increased by 8% (though statistically
significant versus WT), and (3) hundreds of MEF nuclei
were analyzed for pericentric heterochromatin, CENP-A,
and kinetochore foci and all of these were found to be
increased in H3f3b KO MEF nuclei. Though we did ob-
serve an increase in nuclear size, karyotyping analysis in-
dicates similar DNA content between each genotype of
cells (Table 1); thus, one explanation for the higher nu-
clear volume in one of the clones could be due to the
impact that loss of H3f3b or H3.3 protein has on chro-
matin and nuclear structure.
Taken together, our data supports the existing models
of alternate deposition of H3.3-related factors upon H3.3
depletion. However, our data expands on the current
models and suggests that upon H3.3 reduction, other
factors linked to H3.3 deposition such as CENP-A may
spread beyond the borders of their normal domains.
This in turn may result in ectopic heterochromatin re-
gions that alter the recruitment of kinetochore proteins
or other factors involved in the generation of pericentric
heterochromatin domains.
H3.3 has been associated previously with transcrip-
tionally active chromatin domains [1,2], and our data in-
dicate that loss of H3.3 changes the transcriptome, but
only moderately. Consistent with this notion, ChIP-Seq
studies in mouse ES cells indicated that tagged H3.3 was
associated not only with actively transcribed genes, but
also with repressed and poised genes [3]. While genic
H3.3 deposition is strictly HIRA-dependent in ES cells,
such H3.3 enrichment is not required for maintenance
of the ES cell transcriptome [3]. Alternatively, H3.3 may
have a more major role in transcriptome regulation than
apparent in our knockout studies because there could
also be compensatory mechanisms at work that attenu-
ate the measurable effects of decreased H3.3 levels on the
transcriptome. Since total H3 protein levels are notconsistently elevated in the H3f3b KO cells (a
phenomenon observed in the fly with loss of H3.3), it
seems most likely that such compensation would occur
through changes in canonical H3 PTMs to make them
more similar to those in H3.3.
It is also possible that although total H3.3 protein levels
in H3f3b KO MEFs were substantially reduced, we still did
not lower total H3.3 levels far enough (because of the
remaining H3f3a gene) to strongly impact global promoter
chromatin or transcriptional activity. Such a scenario
would depend on the minimum levels of H3.3 protein re-
quired to fulfill these transcription-related functions being
far lower than its other functions (for example, chromo-
some segregation) that were strongly perturbed in the
H3f3b knockout. Alternatively in the context of loss of
H3f3b, remaining H3.3 could be preferentially maintained
near TSSs (where we saw no major change in H3K4me3
by ChIP-Seq). The ontology of the genes that did exhibit
changes in expression in the KO cells was nonetheless
quite interesting. Such changes suggest key links between
H3.3 and core regulatory machinery of cell cycle (in par-
ticular mitosis and DNA synthesis) and chromatin. An-
other interesting possibility is that CENP-A, as a histone
H3 family member, compensated at a transcriptional level
to some extent for the loss of H3.3 by in essence filling in
for H3.3 at TSS regions, which could also explain the ap-
parent ectopic regions of CENP-A staining. Future ChIP-
Seq studies for CENP-A in H3.3 loss-of-function cells will
aid in exploring this possibility.
The links between H3.3 mutations and glioblastoma
[31-33] as well as to cellular reprogramming [7] are im-
portant emerging areas of study. At this time, the func-
tional consequences of the specific K27 and G34
mutations in histone H3.3 remain unknown. Given that
deletions in H3.3 have not to date been observed in tu-
mors, one might speculate that the H3.3 point mutations
in glioblastoma are gain-of-function; however, there is
no direct evidence to this effect. Alternatively, the H3.3
mutations could be either loss-of-function or change-of
-function. The coincident mutations in the H3.3 chaper-
ones DAXX and ATRX might also suggest altered function
of the H3.3 pathway more generally in these tumors. Our
data reported in the current knockout study suggest pos-
sible insights into mechanisms by which changes in H3.3
function might contribute to tumorigenesis. Loss of H3.3
compromised genome integrity, altered chromosome seg-
regation, and changed both the transcriptome and
epigenome. Each of these alterations could be modeled to
contribute to cancer formation.
Future functional genomics and biochemical studies
will likely further clarify the role of histone variant H3.3
in normal and neoplastic cellular functions. Production
of mammalian cells completely lacking all H3.3 protein,
assuming such cells can survive at all (as they do in the
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interrogating H3.3 genomic and biological functions.
Conclusions
Here we report that histone variant H3.3 is required for
normal murine development as targeted disruption of the
H3.3-encoding gene H3f3b leads to numerous defects and
a semi-lethal phenotype in mice. Defects in H3f3b KO cells
include abnormal chromosome segregation and ectopic
CENP-A domains. In addition, loss of H3f3b and lowering
of H3.3 levels induced changes more generally consistent
with spreading of heterochromatin. KOs also displayed ab-
normal cell cycling with cells accumulating in mitosis.
Karyotypic abnormalities including endoreduplication were
observed in KO cells as well. Additionally, H3f3b KO cells
exhibited changes in both the transcriptome and
epigenome. The epigenetic changes in KOs in H3K9ac
and H3K4me3 peaks were, however, not evident specific-
ally near TSSs or centromeres. Overall, these studies pro-
vide novel and important insights into endogenous H3.3
function in development, transcription, epigenetic regula-
tion, and chromosome segregation.
Methods
Additional methodological details can be found in the
Additional file 15.
All animal studies were approved by the University of
California-Davis Institutional Animal Care and Use
Committee (IACUC).
Mouse production and genotyping
H3f3b targeted mES cells (JM8.F6) were produced by elec-
troporation of the targeting vector (Figure 1A) and selec-
tion with G418. Single copy presence of the recombined
allele was verified by genomic PCR. Targeted ES cells were
injected into BALB/c blastocysts. Chimeric mice were bred
with WT and germline transmission judged by coat color
and genomic PCR. All genotyping was performed using
Bioneer AccuPower Pre-mix PCR tubes (http://www.
bioneer.com/), which require only water, DNA and
primerPrimers used (refer to Figure 1A for diagram of
their relative locations indicated by arrows):
1. KO Primer: GCTCGACTAGAGCTTGCGGAAC
2. FL Primer: CTGATGGCGAGCTCAGACCATAAC
3. Common: CAGTTTGAGTGCCTGAGGACAAG
4. WT Primer: GAACTCAGGACCTTAGGATGA
GCAGT
Chromatin immunoprecipitation-sequencing (ChIP-Seq)
Chromatin immunoprecipitation was carried out on
WT1, WT2 and KO1, KO2 MEFs as described [49]. For
more detail see Additional file 15.Acid extracts
Acid extracts were prepared from biological replicates of
H3f3bΔ/Δ and H3f3bWT/WT MEFs according to the Abcam
protocol. Cells were harvested and washed twice with ice-
cold PBS supplemented with 5mM sodium butyrate. Cells
were then incubated in triton extraction buffer (TEB: 0.5%
Triton X-100, 2mM PMSF, 0.02% sodium azide) for 10 -
minutes at 4°C and pelleted. After another TEB wash, his-
tones were extracted in 0.2 N HCl overnight at 4°C. Cells
were pelleted, and supernatant was saved and aliquotted
for immunoblotting. All extracts were neutralized with
NaOH prior to use.
Mouse embryonic fibroblasts isolation
H3f3bΔ/WT mice were crossed, and embryos were isolated
at E12.5. The head and visceral organs were removed and
remaining tissue was trypsinized and disassociated. Tryp-
sin was then neutralized and remaining cells were cultured
with MEF medium (10% FBS, 1% non-essential amino
acids, 1% Glutamine, DMEM). Tissue was removed from
each embryo head to be used for genotyping.
H3f3bFl/Fl MEFs were prepared in a similar manner from
E12.5 embryos obtained by H3f3bFl/Fl by H3f3bFl/WT
crosses.
Antibodies
A list of all antibodies used in this study can be found in
Additional file 16: Table S8.
Immunocytochemistry
WT and KO E12.5 MEFs were plated on gelatin coated
glass cover slips in each well of a six-well plate. After a
day of growth, cells were washed once with 1x PBS, and
fixed for 15 minutes with 4% paraformaldehyde. Cells
were then washed again, and blocked (5% BSA, 3% normal
goat serum, 0.3% Triton X-100 in PBS) for one hour at
room temperature (RT) Primary antibodies were added in
carrier solution (3% normal goat serum, 0.3% Triton X-
100 in PBS) and incubated overnight at 4°C. Cells were
then washed 3×5 min in PBS, then incubated in carrier so-
lution with AlexaFluor 546 or 488 anti-rabbit secondary
IgG. The cover slips were washed four times for 5
minutes each time with PBS and mounted on slides with
Vectashield mounting medium with DAPI (Vector Labs-
http://www.vectorlabs.com/).
To arrest the MEFs, cells were treated with colcemid
(demecolcine) at 0.15 ug/mL. Slides were incubated with
the drug for 4 to 5 hours. For specific antibody dilutions
see Additional file 16: Table S8.
Western blots
Equivalent levels of protein were run through 6 to 12% Bis-
Tris gel as indicated by Invitrogen protocol (http://www.
invitrogen.com/site/us/en/home.html). Protein was then
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brane and blocked in 5% milk. Two methods were
employed when incubating western blots with primary
antibodies. Depending on the antibody, membranes were
either 1) blocked one hour in 5% milk/TBST at RT and
then incubated in primary overnight at 4°C, or 2) blocked
overnight at 4°C in 5% milk/TBST then incubated with
primary for two hours at RT. All secondary antibodies
were applied for 1 hour at RT.
Q-PCR analysis
The TaqMan probe for H3f3b, H3f3a, and the control
housekeeping gene, Eif4g2, were obtained from Applied
Biosystems (http://www.invitrogen.com/site/us/en/home/
brands/taqman.html). Each reaction utilized 10 ng of
cDNA, and separate reactions containing 10 ng of RNA
were used to check for genomic DNA contamination.
Samples were prepared according to Applied Biosystems
protocol, and run on Roche LightCycler 480 with included
software (https://www.roche-applied-science.com/sis/rtpcr/
htc/index.jsp). Results were analyzed using the 2-δδCt
method. All other genes were analyzed using Absolute Blue
QPCR Master Mix (http://www.thermoscientific.com/
ecomm/servlet/productsdetail?productId=11956387) for
SYBR green-based quantitative PCR (qPCR). Fold changes
were normalized to PPIA and analyzed by the 2-δδCt
method. For list of primers used, see Additional file 15.
Gene expression microarray analysis
RNA from constitutive H3f3b KO 1 and KO 2 and WT 1
and WT 2 MEFs was submitted in biological duplicates.
Conditional knockout samples were submitted in analyt-
ical duplicates. A total of 500 ng of RNA from each sam-
ple was used on an Illumina Sentrix Mouse Ref-8
Expression BeadChip (http://www.illumina.com/products/
mouseref-8_v2_expression_beadchip_kit.ilmn) containing
over 25,000 probes. Amplification and hybridization were
performed at the University of California-Davis expression
analysis core according to the Illumina protocol. Microarray




The 10 cm plates of KO 49 and 52 and WT 46 and 48
MEFs were harvested at approximately 70% confluency.
Cells were incubated in a hypotonic lysis/staining solu-
tion (0.1% sodium citrate, 0.1% Triton X-100, 10 μg/mL
propidium iodide, 100 μg/mL RNase A) for 1 to 3 hours
at RT, and then nuclei were analyzed by flow cytometry
on a Dako Cyan ADP. Results were quantified using
Cylchred software (Terry Hoy, Cardiff University; avail-
able upon request).Kinetochore foci and pericentric heterochromatin foci
expression in mouse embryonic fibroblasts
H3f3b WT (n = 94, two clones) and H3f3b KO (n = 81,
two clones) nuclei were stained with CREST serum for
total kinetochore protein expression and with antibodies
recognizing the H3 variant and kinetochore component
CENP-A. An average of 17 confocal sections per nuclei
was analyzed using ImageJ software (http://rsb.info.nih.
gov/ij/) for CREST, CENP-A, and DAPI-positive foci. To
verify our data, we also analyzed a separate set of H3f3b
WT and KO nuclei under identical conditions (n = 91,
two H3f3b WT clones; n = 86, two H3f3b KO clones).Telomere fluorescent in-situ hybridization
These studies were conducted largely as described [50].Data access
ChIP-Seq and Expression Array data sets have accession
numbers [NCBI GEO:GSE34546] and [NCBI-GEO:
GSE35321], respectively.Additional files
Additional file1: Figure S1. (A) Genomic location, (B) genotyping
genomic PCR, and (C) southern blotting assays/probes for H3f3b.
Additional file 2: Figure S2. (A-B) H3f3a mRNA levels in (A) other
knockout (KO) mouse embryonic fibroblasts (MEF) lines produced and
(B) KO embryonic tissue. (C) H3.3 protein levels of total H3.3 protein
levels in other MEF lines produced. (D) Western quantification of H3.3
protein levels in KO 1, 2, 49 and 52. (E) Western quantification of
H3.3S31P protein levels in KO1, 2, 49 and 52 relative to H3.3 protein
levels.
Additional file 3: Figure S3. (A) (top) Example of normal wildtype (WT)
karyotype. (Bottom) Example of knockout 1 (KO1) karyotype exhibiting
breaks. (B) Abnormal shape factor and evidence of elevated levels of
endoreduplication in the KO, DAPI staining and quantitation. Arrows
indicate nuclei with possible endoreduplication. (C) Metaphase spread of
mouse embryonic fibroblasts (MEF) line KO2 show endoreduplication.
(D) DAPI/CREST staining for mouse acrocentric chromosomes and
centromeric regions in WT 63 and KO 56. Scale bar = 10 um. (E)
Immunostaining for total H3 in WT 46 and KO 49 (MEFs). Scale
bar = 20 um.
Additional file 4: Figure S4. Telomere fluorescent in-situ hybridization
(FISH) (green) on wildtype (WT) and H3f3b knockout (KO) cells either
arrested in (i) metaphase or (ii) unsynchronized in interphase.
Additional file 5: Figure S5. (A) Total RNA levels in wildtype (WT) and
knockout (KO) mouse embryonic fibroblasts (MEFs). (B) qPCR validation of
genes downregulated on microarray. (C) Histone genes with upregulated
expression in constitutive KO – array data. (D) Immunoblots of histone
H2b and H4. (E) Western blot and associated quantification of CENP-A
protein in KO 49 and 52 versus mean WT.
Additional file 6: Table S1. Gene expression analysis on constitutive
and conditional mouse embryonic fibroblasts (MEFs) for genes that were
up- or downregulated by at least 2 fold. (P <0.05).
Additional file 7: Table S2. Gene expression analysis on constitutive
and conditional mouse embryonic fibroblasts (MEFs) for genes that were
up- or downregulated by at least 1.5 fold.
Additional file 8: Table S3. Ontological expression analysis on
constitutive mouse embryonic fibroblasts (MEFs) for genes upregulated.
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http://www.epigeneticsandchromatin.com/content/6/1/7Additional file 9: Table S4. Ontological expression analysis on
constitutive mouse embryonic fibroblasts (MEFs) for genes
downregulated.
Additional file 10: Table S5. Basic statistics from the alignment and
peak calling portion of the chromatin immunoprecipitation-sequencing
(ChIP-Seq) analysis. Sequencing reads were aligned using Bowtie,
followed by peak calling using both PeakRanger and Sole Search.
Additional file 11: Figure S6. (A) Chromatin immunoprecipitation-
sequencing (ChIP-Seq) global peak overlap between two biological
replicates for each condition. (B) Average profile of ChIP-Seq peaks in the
region from -1000 to +1000 bp around the transcription start site (TSS) of
genes.
Additional file 12: Table S6. Chromatin immunoprecipitation-
sequencing (ChIP-Seq) differential peak analysis. Differential H3K4me3
and H3K9ac peaks were identified using R package DiffBind with False
Discovery Rate < 0.1. Peak annotations within 30 kb of each peak were
generated using Galaxy Cistrome tool peak2gene.
Additional file 13: Table S7. Ontology of genes within 30 kb of
H3K4me3 peaks that are significantly different in knockout (KO) mouse
embryonic fibroblasts (MEFs) 1 and 2 versus wildtype (WT).
Additional file 14: Figure S7. Histogram of H3K4me3 peaks that are
significantly reduced (top) or increased (bottom) in the knockout (KO)
compared to wildtype (WT), based on two biological replicates for each
genotype. Histograms are divided into one plot for each chromosome.
Chromosomal location is shown on the x-axis, scaled from 0
(centromere) to 1 (telomere); the y-axis shows fold change of significantly
changed peaks (FDR <0.1). Graphs were produced using the R package
ggplot2.
Additional file 15: Supplemental Methods.
Additional file 16: Table S8. Antibody list.
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H3.3S31P: Histone H3.3 phosphorylated at serine 31; ICC-
IC: Immunocytochemistry-Immunofluorescence; KO: Knockout;
MCM: Minichromosome maintenance complex; MEF: Mouse embryonic
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